See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Ligand Pharmaceuticals Incorporated (LGND) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ligand Pharmaceuticals Incorporated (LGND) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for September 4th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 4th:
Interface, Inc. (TILE - Free Report) : This modular flooring company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.4% over the last 60 days.
Interface, Inc. Price and Consensus
Interface, Inc. price-consensus-chart | Interface, Inc. Quote
Interface's shares gained 5.6% over the last one month higher than the S&P 500’s increase of 1.8%. The company possesses a Momentum Score of B.
Interface, Inc. Price
Interface, Inc. price | Interface, Inc. Quote
UFP Technologies, Inc. (UFPT - Free Report) : This designer of natural fiber materials has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 4.8% over the last 60 days.
UFP Technologies, Inc. Price and Consensus
UFP Technologies, Inc. price-consensus-chart | UFP Technologies, Inc. Quote
UFP Technologies' shares gained 4.1% over the last one month higher. The company possesses a Momentum Score of A.
UFP Technologies, Inc. Price
UFP Technologies, Inc. price | UFP Technologies, Inc. Quote
Ligand Pharmaceuticals Incorporated : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 14.4% over the last 60 days.
Ligand Pharmaceuticals Incorporated Price and Consensus
Ligand Pharmaceuticals Incorporated price-consensus-chart | Ligand Pharmaceuticals Incorporated Quote
Ligand Pharmaceuticals' shares gained 14.5% over the last one month higher. The company possesses a Momentum Score of A.
Ligand Pharmaceuticals Incorporated Price
Ligand Pharmaceuticals Incorporated price | Ligand Pharmaceuticals Incorporated Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>